• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性多囊肾病中肾体积的决定因素

Determinants of renal volume in autosomal-dominant polycystic kidney disease.

作者信息

Grantham J J, Cook L T, Torres V E, Bost J E, Chapman A B, Harris P C, Guay-Woodford L M, Bae K T

机构信息

Department of Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.

出版信息

Kidney Int. 2008 Jan;73(1):108-16. doi: 10.1038/sj.ki.5002624. Epub 2007 Oct 24.

DOI:10.1038/sj.ki.5002624
PMID:17960141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2790405/
Abstract

The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) recently showed that renal enlargement in autosomal-dominant polycystic kidney disease mimicked exponential growth. We determined the effects of cyst initiation rate, total number, and growth rate on the time-dependent change of total cyst volume (TCV). Mathematical models with equations integrating cyst surface area, volume, and an invariant growth rate constant were used to compute the time-dependent change in volume of solitary and multiple cysts. Multiple expanding cysts increased TCV in an exponential-like pattern even when individual cysts formed at different rates or exhibited different but constant growth rates. TCV depended on the rate of cyst initiation and on the total number of cysts; however, the compounding effect of exponential-like growth was the most powerful determinant of long-term cyst expansion. Extrapolation of TCV data plots for individual subjects back to an age of 18 predicted TCV values within an established range. We conclude that cysts started early in life were the main contributor to eventual TCV while their growth rate primarily determined renal size; although the rate of formation and the ultimate number of cysts also contributed. The good fit between the exponential models and the extrapolated CRISP data indicates that the TCV growth rate is a defining trait for individual patients and may be used as a prognostic marker.

摘要

多囊肾病放射影像学研究联盟(CRISP)最近表明,常染色体显性多囊肾病中的肾脏增大呈现出指数增长模式。我们确定了囊肿起始率、总数和生长率对总囊肿体积(TCV)随时间变化的影响。使用整合囊肿表面积、体积和恒定生长速率常数的方程的数学模型来计算单个囊肿和多个囊肿体积随时间的变化。即使单个囊肿以不同速率形成或呈现不同但恒定的生长速率,多个不断增大的囊肿也会以指数样模式增加TCV。TCV取决于囊肿起始率和囊肿总数;然而,指数样生长的复合效应是长期囊肿扩张的最有力决定因素。将个体受试者的TCV数据图外推至18岁时,预测的TCV值在既定范围内。我们得出结论,生命早期开始形成的囊肿是最终TCV的主要贡献者,而它们的生长速率主要决定肾脏大小;尽管囊肿的形成速率和最终数量也有影响。指数模型与外推的CRISP数据之间的良好拟合表明,TCV生长速率是个体患者的一个决定性特征,可作为预后标志物。

相似文献

1
Determinants of renal volume in autosomal-dominant polycystic kidney disease.常染色体显性多囊肾病中肾体积的决定因素
Kidney Int. 2008 Jan;73(1):108-16. doi: 10.1038/sj.ki.5002624. Epub 2007 Oct 24.
2
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中肾囊肿数量和体积的生长模式。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833. doi: 10.2215/CJN.10360818. Epub 2019 May 14.
3
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.磁共振弥散加权成像在多囊肾病中肾囊肿体积定量和非囊组织特征分析中的应用。
Eur Radiol. 2023 Sep;33(9):6009-6019. doi: 10.1007/s00330-023-09601-4. Epub 2023 Apr 5.
4
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾血流的磁共振测量与疾病进展
Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. doi: 10.2215/CJN.00910306. Epub 2006 Nov 2.
5
Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.利用多囊肾病中中部层面磁共振图像估算肾和囊肿体积的新方法。
Am J Nephrol. 2013;38(4):333-41. doi: 10.1159/000355375. Epub 2013 Oct 5.
6
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病(ADPKD)早期的肾脏结构:多囊肾病放射影像学研究联盟(CRISP)队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
7
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.从常染色体显性多囊肾病患者的磁共振图像中分割个体肾囊肿。
Clin J Am Soc Nephrol. 2013 Jul;8(7):1089-97. doi: 10.2215/CJN.10561012. Epub 2013 Mar 21.
8
The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者肾囊肿的液体分泌。
N Engl J Med. 1993 Jul 29;329(5):310-3. doi: 10.1056/NEJM199307293290503.
9
Deep learning-based segmentation of kidneys and renal cysts on T2-weighted MRI from patients with autosomal dominant polycystic kidney disease.基于深度学习的常染色体显性多囊肾病患者 T2 加权 MRI 上肾脏和肾囊肿的分割。
Eur Radiol Exp. 2024 Oct 30;8(1):122. doi: 10.1186/s41747-024-00520-7.
10
Novel methodology to evaluate renal cysts in polycystic kidney disease.评估多囊肾病中肾囊肿的新方法。
Am J Nephrol. 2014;39(3):210-7. doi: 10.1159/000358604. Epub 2014 Feb 22.

引用本文的文献

1
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.40岁前发展至肾衰竭的常染色体显性多囊肾病患者的特征
Pediatr Nephrol. 2025 Jun;40(6):1997-2007. doi: 10.1007/s00467-024-06652-7. Epub 2025 Feb 1.
2
Change in kidney volume growth rate and renal outcomes of tolvaptan treatment in autosomal dominant polycystic kidney disease: post-hoc analysis of TEMPO 3:4 trial.托伐普坦治疗常染色体显性遗传性多囊肾病时肾体积生长速率的变化及肾脏转归:TEMPO 3:4试验的事后分析
Clin Exp Nephrol. 2025 May;29(5):638-649. doi: 10.1007/s10157-024-02589-1. Epub 2025 Jan 2.
3
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.用于预防常染色体显性遗传性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3.
4
How histopathological diagnosis interacts with kidney ultrasound parameters and glomerular filtration rate.组织病理学诊断如何与肾脏超声参数和肾小球滤过率相互作用。
Intern Emerg Med. 2024 Nov;19(8):2121-2132. doi: 10.1007/s11739-024-03711-7. Epub 2024 Sep 13.
5
Single-Center Experience of Pediatric Cystic Kidney Disease and Literature Review.小儿多囊肾病的单中心经验及文献综述
Children (Basel). 2024 Mar 25;11(4):392. doi: 10.3390/children11040392.
6
Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis.从细胞极性和纤维化角度看常染色体显性多囊肾病中的新型潜在治疗靶点
Biomol Ther (Seoul). 2024 May 1;32(3):291-300. doi: 10.4062/biomolther.2023.207. Epub 2024 Apr 9.
7
Magnetic resonance imaging based kidney volume assessment for risk stratification in pediatric autosomal dominant polycystic kidney disease.基于磁共振成像的肾脏体积评估在儿童常染色体显性多囊肾病风险分层中的应用
Front Pediatr. 2024 Feb 23;12:1357365. doi: 10.3389/fped.2024.1357365. eCollection 2024.
8
Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study.常染色体显性多囊肾病患者肾衰竭时的高级影像学生物标志物评估:一项试点研究。
Clin Kidney J. 2023 May 23;16(10):1691-1700. doi: 10.1093/ckj/sfad114. eCollection 2023 Oct.
9
Total and Extracellular Vesicle cAMP Contents in Urine Are Associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression.尿液中总环磷酸腺苷(cAMP)含量及细胞外囊泡cAMP含量与常染色体显性多囊肾病(ADPKD)进展相关。
Life (Basel). 2023 Aug 28;13(9):1817. doi: 10.3390/life13091817.
10
Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.常染色体显性多囊肾病的腹部影像学检查:超越总肾体积
J Clin Med. 2023 Aug 5;12(15):5133. doi: 10.3390/jcm12155133.

本文引用的文献

1
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.常染色体显性多囊肾病中的囊肿体积进展:决定临床结局的主要因素
Clin J Am Soc Nephrol. 2006 Jan;1(1):148-57. doi: 10.2215/CJN.00330705. Epub 2005 Oct 19.
2
Specific growth rate versus doubling time for quantitative characterization of tumor growth rate.用于肿瘤生长速率定量表征的比生长速率与倍增时间
Cancer Res. 2007 Apr 15;67(8):3970-5. doi: 10.1158/0008-5472.CAN-06-3822.
3
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.在常染色体显性多囊肾病中,囊肿数量而非囊肿生长速率与突变基因相关。
J Am Soc Nephrol. 2006 Nov;17(11):3013-9. doi: 10.1681/ASN.2006080835. Epub 2006 Oct 11.
4
Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy.了解多囊肾病的致病机制为治疗提供了线索。
Curr Opin Nephrol Hypertens. 2006 Jul;15(4):456-63. doi: 10.1097/01.mnh.0000232888.65895.e7.
5
Volume progression in polycystic kidney disease.多囊肾病中的体积进展
N Engl J Med. 2006 May 18;354(20):2122-30. doi: 10.1056/NEJMoa054341.
6
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.长效生长抑素治疗常染色体显性遗传性多囊肾病的安全性和有效性。
Kidney Int. 2005 Jul;68(1):206-16. doi: 10.1111/j.1523-1755.2005.00395.x.
7
Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.环磷酸腺苷促进人多囊肾上皮细胞的生长和分泌。
Kidney Int. 2004 Sep;66(3):964-73. doi: 10.1111/j.1523-1755.2004.00843.x.
8
Cystic renal disease.
Magn Reson Imaging Clin N Am. 2004 Aug;12(3):449-67, vi. doi: 10.1016/j.mric.2004.03.009.
9
Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer.
Jpn J Clin Oncol. 2004 Feb;34(2):82-5. doi: 10.1093/jjco/hyh011.
10
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.血管加压素V2受体拮抗剂对肾囊性疾病发生发展的抑制作用
Nat Med. 2003 Oct;9(10):1323-6. doi: 10.1038/nm935. Epub 2003 Sep 21.